We use cookies to provide useful features and measure performance to improve your experience on our website. By clicking "Accept all" you agree to the use of all cookies. By clicking on "Show settings", you can adjust your selection.
“It’s a paradigm shift.” This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in communication with sponsors and CROs through the use of mint Lesion™. Together, Ms. Laura Graziani, study coordinator,…
We are very happy to be part of the Brainlab family. We are convinced that together we will make a huge impact on the future of healthcare – and this future has already begun! What does this mean for mint Lesion™ users? Brainlab and…
Medical imaging contributes key diagnostic information to the evidence-based therapeutic decision process. The transformation of radiological images into a digital stream of quantitative diagnostic metadata allows for systematic data integration with other sources of diagnostic data from pathology and laboratory medicine as the basis for…
Join our three Sales Directors, Felix Gruler, Aditya Jayaram, and Steffen Rupp, in their discussion about Mint Medical’s mission statements and how we fill these with life. Be inspired and see how to unleash the full potential of the wealth of radiological data that is…
The long-standing cooperation between Mint Medical GmbH, developer of the leading radiological software platform mint Lesion™ for the standardization of radiological reads and context-driven structured reports, and the LMU University Hospital Munich is being expanded in regard to clinical routine. To date, mint Lesion™ has…
Dr. Laura Oleaga from Hospital Clinìc de Barcelona explains how she and her team have benefitted from implementing mint Lesion™ in the face of an increasing volume of clinical trials. She highlights how standardized reading procedures and reports limit the possibility of errors in clinical…
“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole or per individual trial,” states PD Dr. Wolfgang Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig-Maximilians-University Hospital…
Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs. Faced with a multitude of clinical trial site reads each day,…
Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials and how a software solution for tumor assessment can improve the quality and reproducibility of data, all while saving time. …
Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization (DEB-TACE) using doxorubicin-loaded 40-μm sized microspheres in patients with hepatocellular carcinoma (HCC) in a recent retrospective study [1]. Conventional TACE with lipiodol emulsion is still considered…
